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Abstract: The proportion and number of lymphocytes in the airways were analyzed in
15 patients with a high proportion of lymphocytes in bronchoalveolar lavage (BAL)
fluid (more than 30%) and in 17 patients with less than 20% of BAL lymphocytes. 1.
Both atopic and nonatopic asthma patients with a high proportion of BAL lymphocytes
were aged more than 50 years. In contrast. the age of patients with less than 20% of
BAL lymphocytes ranged widely, from 29 to 63 years, in the two asthma types. 2. Age
at onset of the disease, serum IgE levels, and ventilatory function test were not related
to the proportion of BAL lymphocytes. 3. In patients with a high proportion of BAL
lymphocytes, the mean proportion of these cells was 47.3% in atopic patients and
36.4% in non-atopic patients, i. e., there was no significant difference between the two
asthma types. The absolute number of BAL lymphocytes in these patients was
significantly higher in atopic (5.62X 10 8 ) than in nonatopic asthma (0.77 X10 8 ) (p<O.01).
These findings show that an increased number of lymphocytes in the airways is clearly
related to patient age and IgE-mediated allergic reaction.
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Introduction
IgE-mediated allergy is a major Immu-
nological reaction participating in the patho-
genesis of bronchial asthma (l - 3) ; asth-
ma induced by IgE-mediated allergy is
known as atopic. Thus, bronchial asthma is
usually divided into two types clinically,
atopic and nonatopc, on the basis of the
presence or absence of IgE-mediated allergic
reactions (4), although investigators in sev-
eral studies have suggested that asthma is
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almost always associated with some type of
IgE-related reaction (5, 6). In classifying
asthma by the presence or absence of IgE-
mediated allergic reactions, it has been sug-
gested that there are some differences be-
tween the mechanism of onset in atopic and
nonatopic types.
In recent years, airway inflammation, in
which lymphocytes, neutrophils, eosinophils,
and basophils from the bloodstream are
involved (7 -12), has been noted as a major
causative factor in late asthmatic reaction
(LAR) (13, 14). In the inflammatory process,
blood cells migrate into allergic reaction
sites, and these cells play an important role
in the pathogenesis of asthma.
In the present study, we evaluated the
association between BAL lymphocyte number
and the pathogenesis of asthma in patients
with atopic and nonatopic asthma.
Subjects and Methods
To observe the association between lympho-
cyte number in the airways and the patho-
genesis of asthma, we selected 15 asthma
patients (5 females and 10 males; mean age
62.0 years, range 51 - 73 years) with an
increased proportion of lymphocytes more
than 30% in bronchoalveolar lavage (BAL)
fluid. Seventeen asthma patients (7 females
and 10 males; mean age 47.8 years, range 29-
63 years) with less than 20% of BAL lym-
phocytes were selected as control subjects.
These patients were further divided into two
asthma types, atopic and nonatopic, on the
basis of IgE-mediated allergic reactions (15) :
patients with IgE antibodies to inhalant
allergens or serum IgE level over 500 IU/ ml
were evaluated as atopic, and those with
negative skin reaction to allergens and serum
IgE levels less than 100 IU/ml were
evaluated as nonatopic.
Bronchoalveolar lavage (BAL) was per-
formed after informed consent was obtained
from all subjects. The BAL examination was
carried out, according to a previously
described method (15 - 18), in all subjects
when they were free of attacks. Smear pre-
parations were made with cell suspen-
sions prepared from samples obtained by
bronchofiberscope. Slides containing these
suspensions were air dried and stained with
May Giemsa. BAL cytology was performed
by observing 500 cells, excluding epithelial
cells, on the smear preparations. In this
study, the mean recovery rate at BAL was
28.2 ± 15.2% (10.0% -74.0%) and the total
number of cells aspirated in the BAL fluid
was 5.48 X 10 6 (0.4 X 10 6 - 24.6 X 10 6 ). The
results were expressed as a percentage of the
total cell number and as an absolute count in
BAL fluid.
Ventilatory function tests, using a Box
Spiror 81-S (Chest Co.), was carried out in
all subjects when they were asymptomatic.
Immediate skin reaction to allergens was
determined following the intradermal injec-
tion of 0.02mf of commercial allergen extract
(Torii pharmaceutical Co.). The skin reaction
was measured in millimeters at 20min after
the test. Wheals larger than 9mm or flares
larger than 20mm at 20min were regarded as
positive.
Serum IgE levels were measured by a
radioimmunosorbent test (RIST) and IgE
antibibodies to inhalant allergens were evalu-
ated by a radioallergosorbent test (RAST).
Results
Age of all atopic asthma patients with a
high proportion of BAL lymphocytes (more
than 30%) was more than 50 years (mean
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between the two gi:"OUps. In nonatopic asthma
patients, the serum IgE level was low, and
there was no significant difference between
patients with a high proportion of BAL
lymphocytes (51 ±42 IU/m£) and those with
less than 20% of BAL lymphocytes (71 ±28 I
U/m£).
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59.8 years). In contrast, the age of atopic
asthma patients with less than 20% of BAL
lymphocytes ranged widely, from 29 to 59
years (mean 42.7 years). In nonatopic
asthma, the age of all patients with a high
proportion of BAL lymphocytes was also
more than 50 years (mean 65.3 years), while
in nonatopic patients with less than 20% of
BAL lymphocytes, the age ranged from 50 to
63 years (mean 57.0 years), as shown in Fig.
1. Thus, the age of patients with a high
proportion of BAL lymphocytes was, III
general, high (over 50 years).
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Fig. 2. Age at onset of the disease in atopic
and nonatopic asthma patients in
relation to proportion of BAL lym-
phocytes.
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Fig. 1. Age in atopic and nonatopic asthma
patients in relation to proportion of
BAL lymphocytes.
Figure 2 shows the age at onset of the
disease in all subjects. There was no signifi-
cant difference between atopic asthma pa-
tients with more than 30% of BAL lympho-
cytes and those with less than 20% in age at
onset of the disease. There was also no dif-
ference in age at onset between nonatopic
asthma patients classified by the proportion
of BAL lymphocytes. In atopic athma pa-
tients with a high proportion of BAL lym-
phocytes, the mean level of serum IgE was
726±664 IU/m£, and in those with less than
20% of BAL lymphocytes it was 947 ±808 I
U/m£. There was no significant difference
Table 1 shows the ventilatory function in
patients classified by proportion of BAL
lymphocytes. FEV 1.0% value was lowest in
nonatopic asthma patients with a high pro-
portion of BAL lymphocytes 'and highest in
those with less than 20% of BAL lympho-
cytes. The other ventilatory parameters,
%PEFR, %MMF, %V50, and %V25 were also
lowest in nonatopic asthmatics with a high
proportion of BAL lymphocytes. In patien,ts
classified by the proportion of BAL lympho-
cytes and by IgE-mediated allergic reaction,
however, there were no significant differences
in the values of these ventilatory parameters.
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the mean value was higher in atopic than in
nonatopic asthma, the difference was not
significant. In patients with less than 20% of
BAL lymphocytes, the mean value was higher
in atopic asthma (11.5 ± 5.4%) than III
nonatopic asthma (5.3 ± 4.8%), as shown in
Fig. 3. However, this difference was not
significant.
Table 1. Ventilatory function in patients with
atopic and nonatopic asthma III
relation to proportion of BAl lym-
phocytes.
Asthma %BAL Vantllatory paramaters
typa lymphocytes %FVC FEVI.O% %PEFR %MMF %950 %925
30%< 98.8· 68.1 72.1 43.2 32.4 28.0
±11.2 ± 9.5 ±22.1 ±22.8 ±20.0 ±14.9
Atopic
<20% 89.4 69.1 69.1 40.8 34.9 26.1±11.4 ±13.6 ±25.1 ±24.8 ±19.9 ±18.2
30%< 19.2 58.8 53.1 34.0 23.4 24.1
±11.8 ±18.8 ±18.3 ±40.5 ±30.9 ±31.2
Nonatopic
<20% IOU 18.8 19.3 38.8 29.9 23.2
± 11.1 ±18.1 ±24.3 ±14.1 ±13.9 ± 9.1
• MS8n±SD
In both atopic and nonatopic asthma, the
proportions of macrophages, neutrophils and
eosinophil in BAL fluid were higher in pa-
tients with less than 20% of BAL lympho-
cytes than in those with a high proportion of
BAL lymphocytes. However, this difference
was not significant (Table 2).
Table 2. Cellular composition in BAL fluid of
patients with atopic and nonatopic
asthma in relation to proportion of
BAL lymphocytes.
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Asthma %BAL Mac Lym Neut Eostype lymphocytes
30%< 49.6'" 41.3 1.6 1.5
±11.6 ±11.8 ± 1.6 ±0.8
Atopic
<20% 75.5 11.5 8.6 1.1±20.1 ± 5.4 ±21.6 ±9.8
30%< 56.0 36.4 5.0 2.4
± 6.4 ± 3.6 ± 4.0 ±2.3
Nonatopic
<20% 14.3 5.3 13.2 7.1±26.3 ± 4.8 ±24.9 ±9.8
lI'i Mean±SO. Mac, macrophages; Lym I lymphocytes;
Neut. neutrophils; Eos, eosinophils. .
In patients with a high proportion of BAL
lymphocytes (more than 30%), the mean
value was 47.3±11.8% (range 30.4%-73.7%)
in atopic asthma and 36.4±3.6% (range 31.4
% - 42.1%) in nonatopic asthma. Although
Fig. 3. Proportion of BAL lymphocytes III
patients with atopic (c::::::::J) and
nonatopic asthma (fZ::Zl)
The percent recovery at BAL was signifi-
cantly higher in atopic than in nonatopic
asthma patients with a high proportion of
BAL lymphocytes (p<0.02). The total cell
number in BAL fluid was greatest in atopic
patients with a high proportion of BAL
lymphocytes ; this value was significantly
higher than that in atopic patients with less
than 20% of BAL lymphocytes (p<O.Ol), III
nonatopic patients with more than 30% of
BAL lymphocytes (p<O.Ol), and in nonatopic
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patients with less than 20% of BAL lympho-
cytes (p<O.01). The number of lymphocytes
in the BAL fluid was significantly higher in
atopic than in nonatopic asthma patients
with a high proportion of BAL lymphocytes
(P<O.Ol ; as shown in Table 3 and Fig. 4),
although there was no significant difference
in the proportion of BAL lymphocytes in
these atopic and nonatopic asthma patients.
The numbers of total cells and lymphocytes
per 1m€ of BAL fluid were also significantly
higher in atopic asthma patients with a high
proportion of BAL lymphocytes compared
with those in the other three groups, as
shown in Table 4.
Table 3. BAL findings in patients with atopic
and nonatopic asthma (1)
Asthma %BAl Parcant Total calls No of lymphocytes
typa lymphocytes recovery (X 10') (X10')
30%< 36.2" 11.2
hcd 5.628 '.
±17.8 ± 8.7 ±4.10
Atopic
<20% 26.2 3.4
b 0.40°
±12.5 ± 2.4 ±0.37
30%< 19.8° 2.1
e O.77f
± 7.8 ± 2.1 ±0.77
Nonatopic
<20% 28.1 3.9
d 0.15°
±15.5 ± 3.1 ±0.14
a and b.p<O.02; c,d,e,l,end g.p<O.OI
*Meo"*50
Table 4. BAL findings in patients with atopic
and nonatopic asthma (2)
30%< <20%
Proportion of BAl lymphocytes
Fig. 4. Number of lymphocytes in BAL fluid
of patients with atopic (D) and nonatopic
asthma (~). a, p<0.02.
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It has been suggested that lymphocytes
play an important role in the pathogenesis of
asthma : increased numbers of activated
blood T cells are found during asthma at-
tacks 09. 20), and CD4+ T-Iymphocytes are
reduced in peripheral blood and sequestered
in the lung (21). Thus, the activation of
T-lymphocytes and the production of
lymphokines appear to be involved in the
pathogenesis of asthma (22, 23). It has been
shown, also, that the number of lymphocytes
in BAL fluid is increased in patients with
asthma (24, 25), with the median percentage
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lymphocyte count in asthmatic patients being
14%, while that of controls was 8% (25) :
lymphocyte counts of more than 14% are
unusual in normal subjects (26). It has been
demonstrated that the increase of BAL lym-
phocytes in asthmatics is due to the increase
of T cell subsets (27). Furthemore, it has
been shown that there is a close correlation
between numbers of BAL CD4+, lL2R+ T cells
and numbers of eosinophils, and that the
numbers of activated T cells and eosinophils
are related to the severity of asthma, as
determined by impairment of FEV 1.0% and
increased methacholine bronchial responsive-
ness (28).
In the present study, the clinical features
of asthma patients with a high proportion of
BAL lymphocytes (more than 30%) were
observed in comparison with those with less
than 20% of BAL lymphocytes. The age of
both atopic and nonatopic asthma patients
with a high proportion of BAL lymphocytes
was over 50 years. These results show that
age is one of the factors related to the high
proportion of BAL lymphocytes in the two
asthma types. However, age at onset of the
disease, serum IgE levels, and ventilatory test
results were not related to the proportion of
BAL lymphocytes.
In this study, we selected both atopic and
nonatopic asthma patients with high
proportn of BAL lymphocytes (more than
30%). Although the proportion of BAL lym-
phocytes was not significantly different in
atopic (47.3%) and nonatopic asthma
(36.4%), the mean value was higher in the
former. In contrast, the absolute number of
BAL lymphocytes was significantly higher in
atopic (5.62 X10 6 ) than in nonatopic asthma
(0.77X10 6 ). These results demonstrate that
the number of lymphocytes in the airways is
related to IgE-mediated allegic reaction.
It was unclear from the present study
which factors, except for age, are implicated
in the differences of BAL lymphocyte propor-
tions in atopic asthma. Five of the 9 atopic
patients (55.6%) with a high proportion of
BAL lymphocytes had asthma attacks within
one month after BAL examination. In con-
trast, 2 of the 11 atopic patients 08.2%)
with less than 20% of BAL lymphocytes had
asthma attacks during this period. The num-
ber of patients whose asthma attacks re-
quired glucocorticoid therapy was greater III
atopic patients with a high proportion of
BAL lymphocytes (5/9 ; 55.6%) than in
those with less than 20% of BAL lympho-
cytes (3/11 ; 27.3%). These findings suggest
that an increased number of lymphocytes in
the airways is associated with both the acute
exacerbation and the severity of asthma.
Further studies, including analysis of lympho-
cyte subsets and cell surface markers, are
necessary to clarify the mechanisms responSI-
ble for this phenomenon.
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気管支肺胞洗浄 (BAL)液中のリンパ球頻度
が30%以上の15例および20%以下の17例の気管支
喋息患者を対象に,BAL液中リンパ球頻度と年
齢および IgE系反応との関連について検討を加
えた｡1.BALリンパ球が高頻度 (30%以上)
を示す症例は,アトピー型,非アトピー型を問わ
ず,50才以上の年齢層に多い傾向が見られた｡-
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方,BALリンパ球20%以下の症例の年齢は,29-
63才まで幅広く分布していた｡2.発症年齢,血
清 IgE値,換気機能と BAL液中リンパ球頻度
との間には関連は見られなかった｡3.BAL硬
中リンパ球頻度が高い症例では,アトピー型では
平均リンパ球頻度は47.3%,非アトピー型では36.
4%であったが,両群間には有意の差は見られな
かった｡しかし,BAL液中のリンパ球の絶対数
は,アトピー型 (5.62×106) において,非アト
ピー型 (0.77×106) に比べ有意に高い値を示 し
た (p<0.01)0
これらの結果は,気道内リンパ球の増加は,忠
者年齢とIgE系反応と密接に関連していることを
示唆しているO
